Bio-Techne (NASDAQ:TECH) Upgraded to “Buy” at upgraded shares of Bio-Techne (NASDAQ:TECH – Free Report) from a hold rating to a buy rating in a research report report published on Friday morning. Several other research analysts have also recently commented on TECH. Stephens reiterated an overweight rating and set a $100.00 price target on shares of Bio-Techne in a report on […]

Leave a Reply

Your email address will not be published.

Previous post EchoStar (NASDAQ:SATS) Earns Buy Rating from Analysts at
Next post Gentherm (NASDAQ:THRM) PT Lowered to $70.00 at Craig Hallum